Darren Ming‐Chun Poon
Papers
1
Total Citations
8
H-Index
1
About
Darren Ming‐Chun Poon is a leading urological oncologist whose work bridges clinical practice and public health, particularly in prostate cancer management. His key research areas include uro-oncology, COVID-19’s impact on cancer care, and optimizing treatment protocols for prostate cancer across disease stages. Poon’s major contribution lies in developing evidence-based recommendations for prostate cancer management during the COVID-19 pandemic, ensuring continuity of care while minimizing infection risk. His highly cited paper, “Prostate cancer management in the era of COVID‐19: Recommendations from the Hong Kong Urological Association and Hong Kong Society of Uro‐oncology” (2021, 8 citations), provides critical guidance on prioritizing treatments, adjusting surveillance, and coordinating interdisciplinary care—a framework adopted by clinicians navigating pandemic disruptions. This work underscores his ability to translate real-world challenges into actionable clinical strategies. Beyond this, Poon has contributed to advancing surgical techniques and systemic therapies for prostate cancer, with his research influencing regional and international practice. His achievements include leadership roles in Hong Kong’s urological associations, where he shapes policy and education. For students and researchers, Poon exemplifies how urological oncology can adapt to global health crises while maintaining rigorous, patient-centered care.
Research Focus
Key Achievements
Top Papers
- 1